BCG vaccine cold chain monitoring, knowledge and practice

D. D. Dimitrijevic, Z. Vukovic, S. Sipetic-Grujicic (Belgrade, Serbia & Montenegro)

Source: Annual Congress 2004 - Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Session: Descriptive epidemiology of sarcoidosis, tuberculosis and pneumonia
Session type: Thematic Poster Session
Number: 2268
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. D. Dimitrijevic, Z. Vukovic, S. Sipetic-Grujicic (Belgrade, Serbia & Montenegro). BCG vaccine cold chain monitoring, knowledge and practice. Eur Respir J 2004; 24: Suppl. 48, 2268

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vaccinating children against influenza: a systematic review of the evidence for community protection
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005


The impact of mass BCG vaccination and preventive chemotherapy (PC) to the epidemiology in children
Source: Eur Respir J 2006; 28: Suppl. 50, 15s
Year: 2006

Bacille Calmette–Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway
Source: Eur Respir J, 53 (1) 1801123; 10.1183/13993003.01123-2018
Year: 2019



Assessment of BCG immunization effectiveness in children from TB infection sources
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010

Moving tuberculosis vaccines from theory to practice
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019


The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


BCG vaccination – local skin changes as side effects
Source: Eur Respir J 2006; 28: Suppl. 50, 303s
Year: 2006

Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012


Assessment of medical undergraduates’ relation to pneumococcal conjugate vaccine use
Source: Virtual Congress 2021 – Medical education in respiratory medicine
Year: 2021


Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001



Tuberculine answer and vaccinal scar in different BCG vaccine's doses
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001

Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trial
Source: Eur Respir J 2013; 41: 627-634
Year: 2013



The case for assessing the full value of new tuberculosis vaccines
Source: Eur Respir J, 55 (3) 1902414; 10.1183/13993003.02414-2019
Year: 2020



High pathogenic influenza virus type A H1N1 educational programmes among general practitioners and pediatricians
Source: Annual Congress 2010 - Medical education
Year: 2010

Estimation of efficacy and safety of vaccination against pneumococcus in children with various deviations in a state of health
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012

The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019